Similarly, women with polycystic ovary syndrome (PCOS), a condition that is associated with a variety of metabolic abnormalities, including obesity, IR, and dyslipidemia, have been reported to have lower serum myonectin concentrations than women without PCOS [25]. This evidence concerns the gene ERFE and obesity due to melanocortin 4 receptor deficiency.